SCHEMBL7526392

SCHEMBL7526392

CC(=O)N(c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 1/20 0.56
TSHR P16473 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
NR3C2 P08235 1/20 0.48
KMT2A Q03164 5/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.46
APAF1 O14727 2/20 0.46
HDAC6 Q9UBN7 2/20 0.43
PTGIR P43119 1/20 0.43
PTGDR Q13258 1/20 0.43
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
AGTR2 P50052 1/20 0.42
HPGD P15428 1/20 0.42
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633234 0.92 TSHR (0.56) S100A4TSHRNR3C2KMT2AMEN1
SCHEMBL8044893 0.89 NPSR1 (0.61) S100A4TSHRNPSR1KMT2AMEN1
SCHEMBL741752 0.87 NPSR1 (0.64) TSHRNPSR1KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL8550497 0.85 NPSR1 (0.61) TSHRNPSR1KMT2AMEN1NPC1
SCHEMBL1471487 0.83 NPSR1 (0.54) TSHRNPSR1KMT2AMEN1NPC1
SCHEMBL2095599 0.83 NPSR1 (0.54) S100A4NPSR1NR3C2KMT2ANPC1
SCHEMBL7985347 0.83 NPC1 (0.51) S100A4TSHRNPSR1KMT2AMEN1
SCHEMBL5540103 0.82 NPSR1 (0.52) S100A4TSHRNPSR1NR3C2KMT2A
SCHEMBL2095596 0.82 NPSR1 (0.52) S100A4NPSR1NR3C2KMT2ANPC1
SCHEMBL3975700 0.82 NPSR1 (0.52) TSHRNPSR1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020077318-A1 Substituted azepino[4,5b] indoline derivatives PHARMACIA & UPJOHN COMPANY 2002-06-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077318-A1 Substituted azepino[4,5b] indoline derivatives HTR5A, HTR1A, HTR4 S100A4 2027/4885TSHR 134/4885NPSR1 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.